Free Trial
MarketBeat All Access — Now with A.I. InsightsStart Free For 30 Days

ConvaTec Group (CTEC) Competitors

ConvaTec Group logo
GBX 240 +1.00 (+0.42%)
As of 12:09 PM Eastern
Compare

CTEC vs. AMS, TSTL, BVC, SPEC, AKR, CNSL, ODX, SN, OBI, and DPH

Should you be buying ConvaTec Group stock or one of its competitors? The main competitors of ConvaTec Group include Advanced Medical Solutions Group (AMS), Tristel (TSTL), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), Smith & Nephew (SN), Ondine Biomedical (OBI), and Dechra Pharmaceuticals (DPH). These companies are all part of the "medical" sector.

ConvaTec Group vs. Its Competitors

Advanced Medical Solutions Group (LON:AMS) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

In the previous week, Advanced Medical Solutions Group had 2 more articles in the media than ConvaTec Group. MarketBeat recorded 5 mentions for Advanced Medical Solutions Group and 3 mentions for ConvaTec Group. ConvaTec Group's average media sentiment score of 0.99 beat Advanced Medical Solutions Group's score of 0.94 indicating that ConvaTec Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Advanced Medical Solutions Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ConvaTec Group
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Advanced Medical Solutions Group currently has a consensus target price of GBX 273.67, suggesting a potential upside of 20.56%. ConvaTec Group has a consensus target price of GBX 309.40, suggesting a potential upside of 28.92%. Given ConvaTec Group's higher probable upside, analysts clearly believe ConvaTec Group is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
ConvaTec Group
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Advanced Medical Solutions Group pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.0%. ConvaTec Group pays an annual dividend of GBX 0.07 per share and has a dividend yield of 0.0%. Advanced Medical Solutions Group pays out 62.4% of its earnings in the form of a dividend. ConvaTec Group pays out 63.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£220.30M2.23£11.22M£0.045,443.65
ConvaTec Group£2.36B2.05£188.35M£0.112,264.15

Advanced Medical Solutions Group has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Comparatively, ConvaTec Group has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500.

33.2% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 50.9% of ConvaTec Group shares are owned by institutional investors. 4.1% of Advanced Medical Solutions Group shares are owned by insiders. Comparatively, 0.9% of ConvaTec Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Advanced Medical Solutions Group has a net margin of 8.49% compared to ConvaTec Group's net margin of 6.96%. ConvaTec Group's return on equity of 9.15% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group8.49% 4.57% 2.35%
ConvaTec Group 6.96%9.15%5.01%

Summary

ConvaTec Group beats Advanced Medical Solutions Group on 10 of the 17 factors compared between the two stocks.

Get ConvaTec Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTEC vs. The Competition

Export to Excel
MetricConvaTec GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£4.82B£2.94B£6.10B£2.61B
Dividend Yield2.11%2.04%5.70%5.28%
P/E Ratio2,264.15258.0885.634,442.02
Price / Sales2.0595.00622.26100,236.46
Price / Cash17.01146.5437.7827.90
Price / Book3.002.4313.139.02
Net Income£188.35M£99.80M£3.30B£5.89B
7 Day Performance2.48%2.38%5.27%0.49%
1 Month Performance0.42%3.40%9.92%5.62%
1 Year Performance7.05%117.04%87.69%164.56%

ConvaTec Group Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTEC
ConvaTec Group
4.0134 of 5 stars		GBX 240
+0.4%		GBX 309.40
+28.9%		+5.8%£4.82B£2.36B2,264.1510,000
AMS
Advanced Medical Solutions Group
2.8532 of 5 stars		GBX 224.50
+2.0%		GBX 273.67
+21.9%		N/A£485.21M£177.52M6,907.6910Insider Trade
Gap Up
TSTL
Tristel
0.6649 of 5 stars		GBX 362
-1.5%		GBX 400
+10.5%		-7.2%£172.75M£43.56M2,806.20208
BVC
BATM Advanced Communications
N/AGBX 16.58
+1.1%		N/A-3.3%£72.38M£118.82M-278.10980News Coverage
Analyst Forecast
High Trading Volume
SPEC
INSPECS Group
2.0864 of 5 stars		GBX 39.23
-0.7%		GBX 60
+52.9%		-8.5%£39.89M£195.28M-866.001,673Gap Up
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 2.85
-6.6%		N/A-15.0%£6.78M£8.33M407.143,200Gap Down
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
SN
Smith & Nephew
3.4043 of 5 stars		GBX 1,324
+0.1%		GBX 1,379.33
+4.2%		+18.0%£14.51B£7.08B47.6718,452News Coverage
High Trading Volume
OBI
Ondine Biomedical
N/AC$14.50
flat		N/A+111.5%C$7.50BC$2.05M-207.14N/A
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50M-15,464.002,457

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:CTEC) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners
An Early Move On The Next Shift In Coin
Litecoin is already processing 500,000+ daily transactions, integrated with PayPal and Revolut, and now one fi...
Market Tactic | Sponsoredtc pixel
Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...
Angel Publishing | Sponsoredtc pixel
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...
Paradigm Press | Sponsoredtc pixel
1 Hour Once A Day
My top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...
Base Camp Trading | Sponsoredtc pixel
U.S. Government Blocked NVIDIA’s Buyout… Here’s Why
The U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...
Behind the Markets | Sponsoredtc pixel
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...
Banyan Hill Publishing | Sponsoredtc pixel
Tesla’s $30 trillion pivot
Circle Nov 6 – huge Tesla news? Tesla could be about to change forever. On November 6, insiders are warning...
Altimetry | Sponsoredtc pixel
3 Major A.I. Threats That Could Upend the U.S. Economy
The media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...
Goldco Precious Metals | Sponsoredtc pixel